Pill Identifier Glipizide - NDC 70771-1099
Glipizide
Product Code 70771-1099
Glipizide by Cadila Healthcare Limited is a orange rou tablet extended release about 6 mm in size, imprinted with 3. The product is a human prescription drug with active ingredient(s) glipizide.
Glipizide
Active Ingredient(s): Glipizide
Inactive Ingredient(s):
- ACETYLTRIBUTYL CITRATE
- AMMONIA
- BUTYL ALCOHOL
- FD&C YELLOW NO. 6
- FERROSOFERRIC OXIDE
- HYDROXYETHYL CELLULOSE (2000 CPS AT 1%)
- HYDROXYPROPYL CELLULOSE, UNSPECIFIED
- HYPROMELLOSES
- ISOPROPYL ALCOHOL
- LACTOSE MONOHYDRATE
- MAGNESIUM STEARATE
- METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)
- POLYETHYLENE GLYCOL, UNSPECIFIED
- PROPYLENE GLYCOL
- SHELLAC
- SILICON DIOXIDE
- TITANIUM DIOXIDE
Cadila Healthcare Limited
Product Type: Human Prescription Drug
Dosage Form: Tablet, Extended Release
- Orange (C48331)
Product Packages
NDC Package Code | Package Description |
---|---|
70771-1099-0 | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE |
70771-1099-1 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE |
70771-1099-3 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE |
70771-1099-4 | 10 BLISTER PACK in 1 CARTON > 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (70771-1099-2) |
70771-1099-5 | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE |
70771-1099-6 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE |
70771-1099-9 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE |
* Please review the disclaimer below.
Pill Identification data last updated on: December, 2018
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product. If this is an emergency, call 911 or the national Poison Help hotline at 1-800-222-1222. Most images are not part of the product labels and have not been verified by the labeler company. ALWAYS consult your physician or pharmacist with any medication-related questions.